Krystal Biotech, Inc. is using gene therapy to develop effective and novel treatments for skin diseases.
View all
Axsome Therapeutics
Post IPO Equity • New York, United States
Magenta Therapeutics
Post IPO Equity • Cambridge, United States
Stemline Therapeutics
Post IPO Equity • New York, United States
Nabriva Therapeutics
Post IPO Equity • King of Prussia, United States
Corvus Pharmaceuticals
Post IPO Equity • Burlingame, United States
C4 Therapeutics
Post IPO Equity • Cambridge, United States
Dyne Therapeutics
Post IPO Equity • Cambridge, United States
Adverum Biotech
Post IPO Equity • Redwood City, United States
Quince Therapeutics
Post IPO Equity • South San Francisco, United States
Sigilon Therapeutics
Post IPO Equity • Cambridge, United States
Kodiak
Post IPO Equity • Palo Alto, United States
Kymera Therapeutics
Post IPO Equity • Watertown, United States